Clinical Trial Update: A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating camrelizumab with concurrent chemoradiation for cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN